About Ally Bridge Group
Ally Bridge Group is a Financial Services company based in Hong Kong (China). Private equity and hedge fund investments in healthcare are managed. It operates on a B2B model. Ally Bridge Group has completed 1 acquisition, including Luoxin Pharmaceutical Group. Its focus areas include Investment Industry and Hedge Funds.
Company details
Headquarters of Ally Bridge Group are maintained in Hong Kong, China. Investments through private equity and hedge fund vehicles are directed toward healthcare companies. Opportunities within the healthcare sector are evaluated and funded across international markets. Management services for healthcare portfolios are provided, with emphasis on sector-specific growth and operations. Engagement with global healthcare entities is facilitated by the firm.
- Headquarters Hong Kong, China
- SectorsFinancial Services
- Website ally-bridge.com
- Investments & Acquisitions
People of Ally Bridge Group
24 people are tracked at Ally Bridge Group (13 in leadership, 2 in board & advisors, 9 in team).
| Name | Role | Group |
|---|---|---|
Frank Yu | Founder, CEO & CIO | Leadership |
Yanan Zhou | Head of Legal, Hong Kong | Leadership |
Jessica Cheng | VP of Operations | Leadership |
Charles Chon | Partner & Managing Director | Leadership |
Barney Han | VP, Private Equity & Medical Devices | Leadership |
Michael Bendetson | Director of Legal & Compliance | Leadership |
Charles Wong | CFO, Hong Kong | Leadership |
Tinnie Chau | VP, Biopharma & Biotech Investments | Leadership |
Reese Yeh | Managing Director, Private Equity & Biopharma | Leadership |
Paresh Kumar | Vice President, Biotech Private Equity | Leadership |
Yvonne Wong | Managing Director, Strategic Development | Leadership |
Zain Shekhani | Managing Director, Head Of Investor Relations | Leadership |
Megan MacDonagh | Vice President | Leadership |
Tom Boone | Technical Advisor | Board & advisors |
Luke Li | Technical Advisor | Board & advisors |
Whitney Hu | Associate | Team |
Jiayun Zhou | Analyst | Team |
Windows Fung | Compliance Manager | Team |
Steven Plachtyna | Research Analyst | Team |
Anna Yaeger | Portfolio Manager, New York | Team |
4 more people are available in the full profile.
Complete people profiles for Ally Bridge Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ally Bridge Group
Ally Bridge Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Luoxin Pharmaceutical Group.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer and manufacturer of pharmaceutical products | luoxin.cn | Linyi, China | 2006 | Mar 2017 | $301M |
Complete acquisition details for Ally Bridge Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ally Bridge Group
Complete news archive for Ally Bridge Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ally Bridge Group
Ally Bridge Group is headquartered in Hong Kong, China.
Headquarters of Ally Bridge Group are maintained in Hong Kong, China. Investments through private equity and hedge fund vehicles are directed toward healthcare companies. Opportunities within the healthcare sector are evaluated and funded across international markets. Management services for healthcare portfolios are provided, with emphasis on sector-specific growth and operations. Engagement with global healthcare entities is facilitated by the firm.
Ally Bridge Group has made 1 acquisition, including Luoxin Pharmaceutical Group.